Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAslan Pharmaceut Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Aslan Pharmaceut Earnings Date And Information
Aslan Pharmaceut last posted its earnings results on Friday, August 9th, 2024. The company reported $-0.88 earnings per share for the quarter, topping analysts' consensus estimates of $-3.6 by $2.72. The company had revenue of 0 for the quarter and had revenue of 12.00 M for the year. Aslan Pharmaceut has generated $-11 earnings per share over the last year ($-10.76 diluted earnings per share) and currently has a price-to-earnings ratio of -0.06. Aslan Pharmaceut has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Aslan Pharmaceut Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/30/2024 | Q1 2024 | N/A | -$2.12 | N/A | $0 | $0 |
| 04/12/2024 | Q4 2023 | -$0.61 | -$3.12 | -2.51 | N/A | $0 |
| 09/30/2023 | Q3 2023 | N/A | -$2.24 | N/A | N/A | $0 |
| 08/18/2023 | Q2 2023 | N/A | -$0.44 | N/A | N/A | $12.00 M |
| 03/31/2023 | Q1 2023 | N/A | -$5.16 | N/A | N/A | $0 |
| 03/24/2023 | Q4 2022 | -$7.60 | -$4.16 | 3.44 | N/A | $0 |
| 09/29/2022 | Q3 2022 | N/A | -$3.12 | N/A | N/A | $0 |
| 06/29/2022 | Q2 2022 | N/A | -$3.68 | N/A | N/A | $0 |
| 03/31/2022 | Q1 2022 | N/A | -$3.68 | N/A | N/A | $0 |
| 03/25/2022 | Q4 2021 | -$6.00 | -$2.64 | 3.36 | N/A | $0 |
| 09/29/2021 | Q3 2021 | N/A | -$2.44 | N/A | N/A | $0 |
| 08/06/2021 | Q2 2021 | -$4.40 | -$1.56 | 2.84 | N/A | $0 |
| 03/31/2021 | Q1 2021 | N/A | -$2.60 | N/A | N/A | $0 |
| 04/23/2021 | Q4 2020 | N/A | -$2.88 | N/A | N/A | $0 |
| 09/30/2020 | Q3 2020 | N/A | -$1.72 | N/A | N/A | $0 |
| 10/09/2020 | Q2 2020 | N/A | -$2.08 | N/A | N/A | $0 |
| 03/31/2020 | Q1 2020 | N/A | -$1.60 | N/A | N/A | $0 |
| 04/16/2020 | Q4 2019 | N/A | -$17.56 | N/A | N/A | $0 |
| 10/31/2019 | Q3 2019 | -$8.80 | -$3.24 | 5.56 | N/A | $0 |
| 06/30/2019 | Q2 2019 | N/A | -$4.96 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aslan Pharmaceut Earnings: FAQ's
In the previous quarter, Aslan Pharmaceut (:ASLN) reported $-0.88 earnings per share (EPS) to beat the analysts' consensus estimate of $-3.6 by $2.72.
The conference call for Aslan Pharmaceut's latest earnings report can be listened to online.
The conference call transcript for Aslan Pharmaceut's latest earnings report can be read online.
Aslan Pharmaceut (:ASLN) has a recorded annual revenue of $12.00 M.
Aslan Pharmaceut (:ASLN) has a recorded net income of $-44,219,604.Aslan Pharmaceut has generated $-10.76 earnings per share over the last four quarters.
Aslan Pharmaceut (:ASLN) has a price-to-earnings ratio of -0.06 and price/earnings-to-growth ratio is -0.